Free Trial

Albert Lowe Analyst Performance

Analyst at Craig Hallum

Albert Lowe is a stock analyst at Craig Hallum in the medical sector, covering 7 publicly traded companies. Over the past year, Albert Lowe has issued 6 stock ratings, including strong buy, buy, and hold recommendations. While full access to Albert Lowe's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Albert Lowe's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 1 Years
Buy Recommendations
87.50% 7 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy12.5%1 ratings
Buy75.0%6 ratings
Hold12.5%1 ratings
Sell0.0%0 ratings

Out of 8 total stock ratings issued by Albert Lowe at Craig Hallum, the majority (75.0%) have been Buy recommendations, followed by 12.5% Strong Buy and 12.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
7 companies

Albert Lowe, an analyst at Craig Hallum, currently covers 7 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
7 companies
100.0%

Albert Lowe of Craig Hallum specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
5 companies
71.4%
PHARMACEUTICAL PREPARATIONS
1 company
14.3%
MED INSTRUMENTS
1 company
14.3%

Albert Lowe's Ratings History at Craig Hallum

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
4/27/2026Initiated Coverage$54.37$140.00Buy
Rezolute, Inc. stock logo
RZLT
Rezolute
12/11/2025Downgrade$1.41$2.00Hold
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/4/2025Initiated Coverage$91.91$175.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/4/2025Initiated Coverage$100.49$175.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
6/17/2025Initiated Coverage$18.97$50.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
6/5/2025Upgrade$12.89$60.00Strong-Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
4/11/2025Initiated Coverage$0.71$6.00Buy
Skye Bioscience, Inc. stock logo
SKYE
Skye Bioscience
3/21/2025Lower Price Target$2.14$14.00Buy